论文信息 - EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients - 字舞流文

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

R. Semrau | A. Debucquoy | C. Sempoux | K. Haustermans | M. Bracko | H. Lenz | C. Rödel | A. Hölscher | S. Hu-Lieskovan | M. LaBonte | Dongyun Yang | Wu Zhang | D. Arnold | P. Grimminger | A. Pohl | K. Dellas | V. Velenik | J. Machiels | D. Vallbohmer | M. Bračko